Advertisement

Topics

Strategic Partnership for New Bladder Cancer Diagnostic Test in the UK

06:50 EDT 24 Oct 2017 | Lab Bulletin

Alpha Laboratories Ltd.is delighted to have been appointed as the exclusive distributor for Arquer Diagnostics Ltd in the UK and Republic of Ireland. Arquer (Sunderland, UK) is an in-vitro diagnostic company developing breakthrough diagnostic tests for the detection of bladder and prostate cancer.

David Giles, Chairman of Alpha Laboratories Ltd. confirms the distributor agreement with Nadia Whittley, Arquer CEOIts non-invasive cancer diagnostic tests are based on the MCM5 (minichromosome maintenance protein) platform. The first Arquer product is ADXBLADDER, a bladder cancer diagnostic test, and a number of clinical trials are running to validate many other indications....

Original Article: Strategic Partnership for New Bladder Cancer Diagnostic Test in the UK

NEXT ARTICLE

More From BioPortfolio on "Strategic Partnership for New Bladder Cancer Diagnostic Test in the UK"

Quick Search
Advertisement
 

Relevant Topics

Bladder Cancer
Non-invasive bladder cancer is a cancer that is only in the inner lining of the bladder. Invasive bladder cancer is cancer that has spread into the deeper walls of the bladder. When the cancer has spread outside the bladder to other parts of the body, th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...